PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $120.1 million in its second quarter.
On a per-share basis, the Palo Alto, California-based company said it had a loss of 90 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 42 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
The provider of oncology testing services posted revenue of $335 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $316 million.
Guardant Health expects full-year revenue in the range of $1.34 billion to $1.36 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GH at https://www.zacks.com/ap/GH
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
